While performing a CRISPR screen on a mouse model of lung cancer, Dubrot's team identified the immune regulator Adam2 as a cancer antigen that inhibits tumour antigen presentation and suppresses interferon expression [52]. The gene discussed is ADAM2; the disease is neoplasm.